fda warning letters glp-1 compounders october 2025 unleashes to firms selling compounded GLP-1s FDA Warns Telehealth Companies Over

Miscellaneous Medical/Legal Pitfalls: Misdiagnosis and the failure to diagnose are most commonly associated with nonpigmented oral malignant melanomas

Neurology (1999) 53(9):193742

What if metformin and GLP-1 therapy alone don't achieve my weight loss goals

10.1212/WNL.0000000000003391 506 ZhangJ.LiuK.SunL.YangL.LiuX.ZhuY.et al

Switching to semaglutide may help because the single-receptor approach sometimes produces milder GI effects, but the improvement is not guaranteed

As the New Year approaches, many consumers are comparing prescription-based weight management programs with lower-cost, non-prescription wellness productsespecially products marketed online as "GLP-1 patches." If you have been seeing ads for these and are unsure what is real or just marketing, you are not alone